Wealth Enhancement Trust Services’s Tandem Diabetes Care TNDM Stock Holding History

Wealth Enhancement Trust Services’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15	Buy	+1	New	+$17	﹤0.01%	1513

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wealth Enhancement Trust Services's TNDM Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 1 share worth $15. The stake represents ﹤0.01% of the portfolio and ranks #1513 among its holdings.

150 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Wealth Enhancement Trust Services held 1 share of Tandem Diabetes Care worth $15 as of Q2 2026.
Tandem Diabetes Care was a new Wealth Enhancement Trust Services position in Q2 2026.
Tandem Diabetes Care made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1513 holding.
150 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.